HIV treatment-as-prevention research: taking the right road at the crossroads

Richard Hayes; Sarah Fidler; Anne Cori; Christophe Fraser; Sian Floyd; Helen Ayles; Nulda Beyers; Wafaa El-Sadr; HPTN 071 (PopART) Study Team

doi:10.1371/journal.pmed.1001800

HIV treatment-as-prevention research: taking the right road at the crossroads

PLoS Med. 2015 Mar 10;12(3):e1001800. doi: 10.1371/journal.pmed.1001800. eCollection 2015 Mar.

Authors

Richard Hayes¹, Sarah Fidler², Anne Cori³, Christophe Fraser³, Sian Floyd¹, Helen Ayles⁴, Nulda Beyers⁵, Wafaa El-Sadr⁶; HPTN 071 (PopART) Study Team

Collaborators

Affiliations

¹ London School of Hygiene & Tropical Medicine, Department of Infectious Disease Epidemiology, London, United Kingdom.
² Imperial College London, Department of Medicine, London, United Kingdom.
³ Imperial College London, Department of Infectious Disease Epidemiology, London, United Kingdom.
⁴ ZAMBART, University of Zambia, School of Medicine, Lusaka, Zambia; London School of Hygiene & Tropical Medicine, Department of Clinical Research, London, United Kingdom.
⁵ Desmond Tutu TB Centre, University of Stellenbosch, Department of Paediatrics and Child Health, Stellenbosch, South Africa.
⁶ Columbia University, Mailman School of Public Health, New York, New York, United States of America.

Abstract

Reflecting on a Policy Forum article by Till Bärnighausen and colleagues, the HPTN 071 (PopART) Study Team consider ethical and study power concerns and the importance of the trial's future findings.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

HIV Infections / drug therapy
HIV Infections / prevention & control*
Health Services Research* / ethics
Health Services Research* / methods
Humans

Abstract

Publication types

MeSH terms

Grants and funding